Literature DB >> 23956870

Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus.

Carmelo Capula1, Eusebio Chiefari, Anna Vero, Stefania Iiritano, Biagio Arcidiacono, Luigi Puccio, Vittorio Pullano, Daniela Foti, Antonio Brunetti, Raffaella Vero.   

Abstract

Postpartum screening is critical for early identification of type 2 diabetes in women previously diagnosed with gestational diabetes mellitus (GDM). Nevertheless, its rate remains disappointingly low. Thus, we plan to examine the rate of postpartum glucose tolerance test (ppOGTT) for Italian women with GDM, before and after counseling, and identify demographic, clinical, and/or biochemical predictors of adherence. With these aims, we retrospectively enrolled 1159 women with GDM, in Calabria, Southern Italy, between 2004 and 2011. During the last year, verbal and written counseling on the importance of followup was introduced. Data were analyzed by multiple regression analysis. A significant increase of the return rate was observed following introduction of the counseling [adjusted odds ratio (AOR) 5.17 (95% CI, 3.83-6.97), P < 0.001]. Interestingly, previous diagnosis of polycystic ovary syndrome (PCOS) emerged as the major predictor of postpartum followup [AOR 5.27 (95% CI, 3.51-8.70), P < 0.001], even after stratification for the absence of counseling. Previous diagnosis of GDM, higher educational status, and insulin treatment were also relevant predictors. Overall, our data indicate that counseling intervention is effective, even if many women fail to return, whereas PCOS represents a new strong predictor of adherence to postpartum testing.

Entities:  

Year:  2013        PMID: 23956870      PMCID: PMC3730210          DOI: 10.1155/2013/182505

Source DB:  PubMed          Journal:  ISRN Endocrinol        ISSN: 2090-4630


1. Introduction

Gestational diabetes mellitus (GDM) is historically defined as “any degree of glucose intolerance with onset or first recognition during pregnancy” [1]. Incidence of GDM is increasing worldwide for recent trends in obesity and advancing maternal age, significantly contributing to increased overall health-care and economic costs [2, 3]. Approximately 7% of all pregnancies are complicated by GDM, resulting in more than 200,000 cases annually [4-7]. Women with GDM are at high risk for short pregnancy complications, such as gestational hypertensive disorders, fetal macrosomia, shoulder dystocia, and cesarean delivery [8-10]. In addition, GDM constitutes a high risk for future type 2 diabetes mellitus (DM) and cardiovascular disease [11-13]. In particular, women with GDM, even with mild glucose intolerance, have up to seven times more risk of developing type 2 DM compared to women with normoglycemic pregnancies [13-15], thus justifying recently recommended tighter diagnostic criteria for GDM [16]. Based on the compelling evidence that lifestyle intervention can effectively prevent or delay the development of type 2 DM [17-19], early identification of women at high risk of diabetes is very important. In this regard, postpartum is a critical period for early diagnosis and for planning prevention and intervention strategies [20-24]. Consistently, the Fifth International Workshop-Conference on Gestational Diabetes Mellitus Panel recommends that women with GDM have a 2-hour 75 gr oral glucose tolerance test (OGTT) at 6 weeks to 12 weeks postpartum [25]. Nevertheless, the majority of women fail to return for postpartum oral glucose testing (ppOGTT) [26-30]. Many reasons have been proposed for such lack of compliance, including poor communication between obstetrician and primary care provider, some confusion over the current guidelines, poor bridging from antepartum to postpartum care, lack of patient awareness, and a certain lack of interest in patient's personal health [30-32]. Therefore, in the last years, many tools have been tested to improve the coverage of screened women, including education intervention among women diagnosed with GDM, automated orders to primary care providers, and telephone and e-mail reminder messages to patients [33-37]. Based on this background, we designed a retrospective study in an Italian population in order to examine adherence rate to ppOGTT and evaluate the efficacy of educational intervention, identifying what are the predictor factors of compliance.

2. Methods

2.1. Study Population

6770 Caucasian pregnant women attended the Hospital “Pugliese-Ciaccio” in Catanzaro (Calabria, Southern Italy), from January 2004 to December 2011, for GDM screening. Out of these, 1159 (17.1%) were diagnosed with GDM, following the current criteria [16, 38]. All consecutive pregnant women with GDM were included, except those with preexisting diabetes, as defined by ADA criteria [1]. Anamnestic information was obtained regarding age, instruction level, parity, previous GDM, family history of diabetes, self-reported prepregnancy weight, and previous polycystic ovary syndrome (PCOS), as diagnosed according to the Rotterdam criteria [39]. To promote adherence to ppOGTT, after January 2011, verbal and written counseling was given to 247 women at 35–40 weeks of pregnancy: they were informed about the increased risk for type 2 DM and about the risks to start a new pregnancy in the presence of glucose intolerance. Then, pregnant ones were provided with a simple handout illustrating the risk of GDM, follow-up recommendations, and suggestions for a correct lifestyle, as type 2 DM preventive strategy. The study was approved by the local ethics committee.

2.2. Statistical Analysis

The nonparametric Mann-Whitney U test was used for comparisons of continuous variables and the 2-tailed Fisher exact test was used for comparisons of proportions. Generally, a significance level of 0.05 was set for a type I error in all analyses. Logistic regression analysis was used to evaluate individual effects of each patient's categorical characteristic, including counseling as possible predictor of ppOGTT postpartum testing. Odds Ratios (ORs) with 95% confidence bounds were calculated. Linear regression analysis was employed to test the association of continue variables with adherence to followup. Each quantitative trait was tested for normality using the Shapiro-Wilk normality test and, when required, it was log-transformed. Data were analyzed with the SPSS 20.0 software. Post hoc statistical power calculations were performed using G∗Power software 3.1.3 (Franz Faul, Kiel University, Kiel, Germany).

3. Results

1159 women were diagnosed as affected by GDM. Out of these, 374 (32.3%) underwent postpartum diabetes screening whereas the remaining 785 (67.7%) did not. Table 1 summarizes demographic, anthropometric, clinical, and biochemical characteristics of both cohorts. Age at diagnosis, prevalence of previous GDM, instruction level, PCOS, fasting plasma glucose, and prevalence of insulin treatment were higher in the group adherent to followup compared with the group not adherent to followup. No difference was observed for prepregnancy BMI, familiarity for type 2 DM, and parity (Table 1).
Table 1

General characteristics of the GDM population.

Followup (n = 374)No followup (n = 785) P value
RaceCaucasianCaucasian
Age (yr), median3633<0.001
 Range18–4818–46
BMI (kg/m2), median25.324.50.175
 Range19–44.817.6–45
Familiarity for type 2 DM (n)2705350.150
Previous GDM7245<0.001
Parity (n), median 220.177
 Range1–51–6
 >12074380.900
Educational status
 Low71384<0.001
 Middle256356<0.001
 High4745<0.001
FPG (mg/dL), median94920.020
 Range70–12172–126
Insulin treatment1472530.021
PCOS7237<0.001

Mann-Whitney U test was used for comparison of continuous traits. 2-tailed Fisher exact test was used for comparison of proportions. SD: standard deviation; BMI: body mass index; low educational status: primary school; middle educational status: secondary school; high educational status: university degree; FPG: fasting plasma glucose; PCOS: polycystic ovary syndrome.

3.1. Counseling Effectiveness

To test the effectiveness of verbal and written counseling, we compared the return rate of women receiving this intervention (62.3%, 154/247) with that of women who did not receive this intervention (24.1%, 220/912) (Figure 1). After adjustment for possible confounders, logistic regression analysis showed a strong association between counseling intervention and adherence to ppOGTT [adjusted OR (AOR) 5.17 (95% CI, 3.83–6.97), P < 0.001] (Table 2). After suitable stratifications, adherence to followup appeared higher among women with middle/high educational status [AOR 5.25 (95% CI, 3.60–7.65), P < 0.001] with respect to women with lower educational status [AOR 4.08 (95% CI, 2.26–7.38), P < 0.001]; higher among women ≥30 years old [AOR 5.64 (95% CI, 3.90–8.14), P < 0.001], compared with younger women [AOR 4.66 (95% CI, 2.71–8.01), P < 0.001]; higher among multigravid women [AOR 5.91 (95% CI, 3.93–8.89), P < 0.001] with respect to primigravidas [AOR 4.46 (95% CI, 2.86–6.94), P < 0.001] (Table 2). In all cases statistical power exceeded 95%.
Figure 1

Adherence to ppOGTT in women with no counseling or after counseling. Gray bars, total women. Black bars, compliant women.

Table 2

Effect of counseling on follow-up adherence.

StratificationFollowup (n = 374)No followup (n = 785)OR (95% CI) P valueStatistical power
Counseling (n)None154935.17 (3.83–6.97)<0.001>95.0%
No counseling (n)220692

Counseling (n)Low educational status24474.08 (2.26–7.38)<0.001>95.0%
No counseling (n)43341
Counseling (n)Middle/high educational status1301735.25 (3.60–7.65)<0.001>95.0%
No counseling (n)50351

Counseling (n)Age ≤ 30 yr40584.66 (2.71–8.01)<0.001>95.0%
No counseling (n)30190
Counseling (n)Age ≥ 31 yr1081685.64 (3.90–8.14)<0.001>95.0%
No counseling (n)56509

Counseling (n)Parity = 1671004.46 (2.86–6.94)<0.001>95.0%
No counseling (n)45301
Counseling (n)Parity ≥ 2871205.91 (3.93–8.89)<0.001>95.0%
No counseling (n)48391

ORs (95% CI) were estimated using logistic regression models adjusted for prepregnancy BMI, familial history of type 2 DM, previous GDM, parity. Post-hoc statistical power calculations were performed using G∗Power software 3.1, entering R-squared multiple correlation coefficient obtained with regression for each trait.

3.2. Other Predictors of ppOGTT

To identify other predictors of ppOGTT, clinical and biochemical parameters that may influence screening rates were employed into a logistic regression analysis (Table 3(a)). As expected, a previous diagnosis of GDM, as well as a higher educational status, strongly correlated with a better adherence to ppOGTT [AOR 4.82 (95% CI, 3.17–7.33), P < 0.001, and AOR 4.06 (95% CI, 3.02–5.45) P < 0.001, resp.] (Table 3(a)). Also, insulin treatment during pregnancy was a predictor of follow-up adherence [AOR 2.32 (95% CI, 1.76–3.05), P < 0.001]. A mild association between prepregnancy BMI and ppOGTT was observed among overweight/obese women when compared with lean women [AOR 1.41 (95% CI, 1.09–1.81), P = 0.008] (Table 3(a)). Interestingly, a previous diagnosis of PCOS emerged as the major predictor of postpartum evaluation of glucose tolerance in women with GDM [AOR 5.27 (95% CI, 3.36–8.27), P < 0.001] (Table 3(a)). No association was observed with other factors, such as family history of type 2 DM and parity (Table 3(a)). To exclude influence of counseling intervention on detected predictors, a multiple regression analysis, after stratification for the absence of counseling, has been performed. As shown in Table 3(a), no substantial change emerged for any factor, indicating that their predicting effect was independent of counseling. When continuous variables were tested, significant association of ppOGTT was observed with earlier diagnosis of GDM (P < 0.001) and age (P < 0.001) and fasting plasma glucose (P = 0.027) at diagnosis of GDM (Table 3(b)). For all these traits statistical power exceeded 95%.

4. Discussion

Herein, we investigated the rate of ppOGTT in Calabrian women, a Southern Italian population characterized by higher prevalence of GDM, type 2 DM, and obesity, as compared to the entire Italian population (http://www.istat.it). As reported in this study, pregnant women who underwent prepartum counseling had a significantly better follow-up adherence rate than those who had no counseling. Counseling was more effectiveness in older women and in women with higher educational level and with previous pregnancies. This is consistent with a major degree of awareness of health risks in these women with respect to younger women, women with low educational status, or primigravidas. For the first time, previous diagnosis of PCOS emerged as the stronger predictor of ppOGTT, with a similar and independent strength with respect to counseling. As an explanation for this, women with PCOS might be more willing to accept medical recommendations, since they often experience unpleasant clinical manifestations such as menstrual irregularity, infertility, and hirsutism. Moreover, because patients with PCOS are often treated with metformin, a widely used antidiabetic drug, these women might be more aware of the risk of type 2 DM and might have more contacts within the health-care system. In a similar way to other reports [26, 27, 40], our results indicate that the most compliant ones were older women, with a previous diagnosis of GDM, higher educational levels, overweight, or obese and those with insulin treatment, higher FPG, and an early diagnosis of GDM. It is plausible that these women may have had greater awareness of their risk for becoming diabetics.

5. Conclusions

In summary, we show that counseling is an effective, inexpensive, and simple tool in increasing ppOGTT rates for women with GDM. Moreover, patients with a previous diagnosis of PCOS were found to be significantly associated with a higher compliance rate for this test. Therefore, counseling can be more effectively targeted based on these observations. Further studies are needed to see whether our findings can be generalized to other populations.

(a)  

Followup (n = 374)No followup (n = 785)OR 1 (95% CI) P value 1Statistical powerOR 2 (95% CI) P value 2
Age (≥31 yr versus ≤30 yr)69 versus 305174 versus 6111.18 (0.89–1.58)0.24222.1%1.27 (0.88–1.82)0.198
Familiarity for type 2 DM (%)270 (72.2)535 (68.2)1.21 (0.92–1.58)0.17831.6%0.94 (0.68–1.31)0.097
Prepregnancy BMI (kg/m2)
 <25 versus ≥25174 versus 200426 versus 3591.41 (1.09–1.81)0.00881.5%1.74 (1.27–2.37)0.001
Previous GDM (%)72 (19.3)45 (5.7)4.82 (3.17–7.33)<0.001>95.0%5.30 (3.26–8.61)<0.001
Parity (1 versus ≥2)167 versus 207346 versus 4391.03 (0.80–1.32)0.8005.7%1.11 (0.82–1.51)0.500
Educational status
 Middle/high versus low303 versus 71401 versus 3844.06 (3.02–5.45)<0.001>95.0%3.54 (2.48–5.06)<0.001
Insulin treatment (%)147 (39.3)253 (32.2)2.32 (1.76–3.05)<0.001>95.0%2.63 (1.90–3.66)<0.001
PCOS (%)72 (19.3)37 (4.7)5.27 (3.36–8.27)<0.001>95.0%5.36 (3.24–8.85)<0.001

OR 1: odd ratio after adjustment for any possible confounder; OR 2: As OR 1, but after stratification for absence of counseling; CI: confidence interval; Post-hoc statistical power calculations were performed using G∗Power software 3.1, entering R-squared multiple correlation coefficient obtained with regression for each trait. Low educational status: primary school; middle educational status: secondary school; high educational status: university degree; PCOS: polycystic ovary syndrome.

(b)  

Followup (n = 374)No followup (n = 785) P valueStatistical power
Age (yr), mean ± SD34.5 ± 5.233.1 ± 4.8<0.001>95.0%
Prepregnancy BMI (kg/m2), mean ± SD25.9 ± 4.525.7 ± 4.70.26567.4%
FPG (mg/dL), mean ± SD92.8 ± 9.091.2 ± 10.70.027>95.0%
Week at diagnosis (n), mean ± SD25.3 ± 4.927.2 ± 3.4<0.001>95.0%

Continuous variables were compared using linear regression models adjusted for familial history of type 2 DM, parity, and prepregnancy BMI (when appropriate). Post-hoc statistical power calculations were performed using G∗Power software 3.1, entering partial R-squared obtained with regression for each trait. FPG: fasting plasma glucose; PCOS: polycystic ovary syndrome. All variables have been log-transformed to better approximate a normal distribution.

  40 in total

Review 1.  Gestational diabetes mellitus.

Authors:  L Jovanovic; D J Pettitt
Journal:  JAMA       Date:  2001-11-28       Impact factor: 56.272

2.  Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus.

Authors:  Marina Stasenko; Jennifer Liddell; Yvonne W Cheng; Teresa N Sparks; Molly Killion; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2011-04-22       Impact factor: 8.661

Review 3.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

4.  A system-based intervention to improve postpartum diabetes screening among women with gestational diabetes.

Authors:  Kimberly K Vesco; Patricia M Dietz; Joanna Bulkley; F Carol Bruce; William M Callaghan; Lucinda England; Terry Kimes; Donald J Bachman; Karen J Hartinger; Mark C Hornbrook
Journal:  Am J Obstet Gynecol       Date:  2012-08-16       Impact factor: 8.661

Review 5.  Gestational diabetes: implications for cardiovascular health.

Authors:  Shannon D Sullivan; Jason G Umans; Robert Ratner
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

6.  Rates of postpartum glucose testing after gestational diabetes mellitus.

Authors:  Michelle A Russell; Maureen G Phipps; Courtney L Olson; H Gilbert Welch; Marshall W Carpenter
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

7.  Gestational diabetes in the United States: temporal trends 1989 through 2004.

Authors:  Darios Getahun; Carl Nath; Cande V Ananth; Martin R Chavez; John C Smulian
Journal:  Am J Obstet Gynecol       Date:  2008-02-15       Impact factor: 8.661

8.  The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes.

Authors:  Jarosław Ogonowski; Tomasz Miazgowski
Journal:  Diabetes Res Clin Pract       Date:  2009-05-05       Impact factor: 5.602

9.  Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David Williams
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

10.  Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study.

Authors:  Assiamira Ferrara; Tiffany Peng; Catherine Kim
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 17.152

View more
  7 in total

Review 1.  Postpartum glucose intolerance: an updated overview.

Authors:  Ida Pastore; Eusebio Chiefari; Raffaella Vero; Antonio Brunetti
Journal:  Endocrine       Date:  2017-08-14       Impact factor: 3.633

2.  Knowledge on postpartum type-2 diabetes mellitus screening among pregnant women with gestational diabetes mellitus in Malaysia.

Authors:  Halimatus Sakdiah Minhat; Puganeswary Thangarajah; Norliza Ahmad
Journal:  Malays Fam Physician       Date:  2022-05-15

3.  Clinical predictors for diabetes screening in the first year postpartum after gestational diabetes.

Authors:  Patricia Peticca; Baiju R Shah; Alison Shea; Heather D Clark; Janine C Malcolm; Mark Walker; Alan Karovitch; Pauline Brazeau-Gravelle; Erin J Keely
Journal:  Obstet Med       Date:  2014-04-14

4.  Glucose intolerance after a recent history of gestational diabetes.

Authors:  Katrien Benhalima; Liesbeth Leuridan; Peggy Calewaert; Roland Devlieger; Johan Verhaeghe; Chantal Mathieu
Journal:  Int J Endocrinol       Date:  2014-08-07       Impact factor: 3.257

5.  Effectiveness of Mobile Call Reminders and Health Information Booklet to Improve Postnatal Blood Glucose Monitoring among Mothers with Gestational Diabetes Mellitus Receiving Care from a Tertiary Health Centre, Puducherry - A Randomized Controlled Trial.

Authors:  Nandhini Manoharan; Venkatachalam Jayaseelan; Sitanshu Sekhar Kar; Nivedita Jha
Journal:  Indian J Endocrinol Metab       Date:  2022-09-20

6.  Gestational diabetes mellitus: screening and outcomes in southern italian pregnant women.

Authors:  Carmelo Capula; Eusebio Chiefari; Anna Vero; Biagio Arcidiacono; Stefania Iiritano; Luigi Puccio; Vittorio Pullano; Daniela P Foti; Antonio Brunetti; Raffaella Vero
Journal:  ISRN Endocrinol       Date:  2013-09-05

7.  Factors Associated with Postpartum Glucose Testing Following Gestational Diabetes Mellitus.

Authors:  Fatin Aina Abu Bakar; Tengku Alina Tengku Ismail
Journal:  Oman Med J       Date:  2021-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.